<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ELN</title>
    <link />
    <description>Headlines for Elan</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Alkermes Reports Earnings for Q4 - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/100037/alkermes-reports-earnings-for-q4.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 23 May 2013 18:07:01 GMT</pubDate>
    </item>
    <item>
      <title>Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/23/elan-announces-pricing-of-us850-million-in-aggrega/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 23 May 2013 16:51:19 GMT</pubDate>
    </item>
    <item>
      <title>Elan Rejects Latest Royalty Pharma Approach</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130523-000697&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Thu, 23 May 2013 14:55:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Big Stocks on Traders' Radars</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/3-big-stocks-traders-radars.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 23 May 2013 14:50:00 GMT</pubDate>
    </item>
    <item>
      <title>Elan Corporation, plc’s Board of Directors Unanimously Reject Royalty Pharma’s Revised Tender Offer</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/23/elan-corporation-plcs-board-of-directors-unanimous/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 23 May 2013 12:05:13 GMT</pubDate>
    </item>
    <item>
      <title>Royalty Pharma Lowers Acceptance Threshold For Elan Offer</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130523-000434&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Thu, 23 May 2013 08:17:00 GMT</pubDate>
    </item>
    <item>
      <title>Royalty Pharma Waives Down Acceptance Condition to 50% of Elan Shares, Plus One Share</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3614909/royalty-pharma-waives-down-acceptance-condition-to-50-of-elan-shares-plus-one-sha.aspx</link>
      <author>Benzinga</author>
      <pubDate>Thu, 23 May 2013 06:34:22 GMT</pubDate>
    </item>
    <item>
      <title>Elan Provides Strategic Update - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99836/elan-provides-strategic-update.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 21 May 2013 21:16:01 GMT</pubDate>
    </item>
    <item>
      <title>When Savvy Dealmaking Borders on Reckless Spending</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/21/when-savvy-dealmaking-borders-on-reckless-spending/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 21 May 2013 18:27:00 GMT</pubDate>
    </item>
    <item>
      <title>Elan Proposes Sweeping Transformation</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/elan-proposes-sweeping-transformation/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 16:37:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Companies: The FDA Doesn't Care About Your Phase 3 Trials</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/biotech-companies-the-fda-doesnt-care-about-your-p/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 16:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Royalty Pharma Raises Takeover Bid for Elan</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130520-000372&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Mon, 20 May 2013 15:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Elan’s Response to Royalty Pharma Announcement</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/elans-response-to-royalty-pharma-announcement/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 13:20:22 GMT</pubDate>
    </item>
    <item>
      <title>Elan Issues Response to Royalty Pharma Bid, Tells Holders to Take No Action</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3604479/elan-issues-response-to-royalty-pharma-bid-tells-holders-to-take-no-action.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 20 May 2013 13:04:36 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Royalty Pharma Confirms Increased $12.50/Share Cash Bid for Elan</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3604211/update-royalty-pharma-confirms-increased-12-50share-cash-bid-for-elan.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 20 May 2013 11:46:42 GMT</pubDate>
    </item>
    <item>
      <title>Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes D</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/elan-announces-proposed-offering-of-us8000-million/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 09:43:19 GMT</pubDate>
    </item>
    <item>
      <title>Elan Announces Transactions: Decisively Transforming the Company</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/elan-announces-transactions-decisively-transformin/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 09:43:08 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/this-week-in-biotech-27/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 13:45:00 GMT</pubDate>
    </item>
    <item>
      <title>The Billion Dollar COPD Deal: Who Gains The Most?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1443651-the-billion-dollar-copd-deal-who-gains-the-most.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 17 May 2013 11:27:18 GMT</pubDate>
    </item>
    <item>
      <title>Here's What Super-Investor Seth Klarman Has Been Buying</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/16/heres-what-super-investor-seth-klarman-has-been-2/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 16 May 2013 18:45:00 GMT</pubDate>
    </item>
  </channel>
</rss>
